Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3528-3536

  Choi, Noah C ^a   Herndon II, James E ^a   Rosenman, Julian ^a   Carey, Robert W ^a   Chung, Chung T ^a   Bernard, Stephen ^a   Leone, Louis ^a   Seagren, Stephen ^a   Green, Mark ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; LUNG TOXICITY; MALE; MUCOSA INFLAMMATION; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

EID: 0031734992     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3528     Document Type: Article

References (34)

1. Perry MC, Eaton WL, Propert KJ, et al: Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 316:912-918, 1987
2. Bunn PA Jr, Lichter AS, Makuch RW, et al: Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small-cell lung cancer. Ann Intern Med 106:655-662, 1987
3. Choi NC, Carey RW, Kaufman SD, et al: Small cell carcinoma of the lung: A progress report of 15 years' experience. Cancer 59:6-14, 1987
4. Cox JD, Byhardt R, Komaki R, et al: Interaction of the thoracic irradiation and chemotherapy on local control and survival in small-cell carcinoma of the lung. Cancer Treat Rep 63:1251-1255, 1979
5. Arriagada R, Kramar A, Le Chevalier T, et al: Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol 10:447-451, 1992
6. Lichter AS, Turrisi AT: Small cell lung cancer: The influence of dose and treatment volume on outcome. Semin Radiat Oncol 5:44-49, 1995
7. Elkind MM, Sutton H: Radiation response of mammalian cells grown in culture. I. Repair of x-ray damage in surviving Chinese hamster cells. Radiat Res 35:556-593, 1960
8. Noron T, Onyango J: Radiotherapy in Burkitt's lymphoma: Conventional versus superfractionation regime - Early results. Int J Radiat Oncol Biol Phys 2:399-406, 1977
9. Suit HD: Superfractionation. Int J Radiat Oncol Biol Phys 2:591-592, 1977 (editorial)
10. Withers HR: Biologic basis for altered fractionation schemes. Cancer 55:2086-2095, 1985
11. Thames HD, Peters LJ, Withers HR, Fletcher GH: Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day. Int J Radiat Oncol Biol Phys 9:127-138, 1983
12. Withers HR: Cell cycle redistribution as a factor in multifraction irradiation. Radiology 114:199-202, 1975
13. Peters LJ, Ang KK: Unconventional fractionation schemes in radiotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, PA, Lippincott, 1986, pp 269-286
14. Choi NC, Propert K, Carey R, et al: Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase 11 study of Cancer and Leukemia Group B. Int J Radiat Oncology Biol Phys 13:263-266, 1987
15. Choi NC, Kanarek DJ, Kazemi H: Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary function studies in predicting postradiotherapy pulmonary function before radiotherapy. Cancer Treat Symp 2:119-130, 1985
16. Kwiatkowski DJ, Propert KJ, Carey RW, et al: A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small cell lung cancer. J Clin Oncol 5:1874-1879, 1987
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Arriagada R, Le Chevalier T, Ruffle P, et al: Alternating radiotherapy and chemotherapy in limited small cell lung cancer: The IGR protocols. Lung Cancer 10:S29-S298, 1994 (suppl)
19. Johnson DH, Bass D, Einhorn LH, et al: Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of the Southeastern Cancer Study Group. J Clin Oncol 11:1223-1229, 1993
20. Kies MS, Mira JG, Crowley JJ, et al: Multimodal therapy for limited small-cell lung cancer: A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; And with wide-field versus reduced-field radiation in partial responders: A Southwest Oncology Group study. J Clin Oncol 5:592-600, 1987
21. Perez CA, Oldham ERK, Greco FA, et al: Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report. J Clin Oncol 2:1200-1208, 1984
22. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl Med 327:1618-1624, 1992
23. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
24. Choi CH, Carey RW: Small-cell anaplastic carcinoma of lung: Reappraisal of current management. Cancer 37:2651-2657, 1976
25. Choi NC, Carey RW: Importance of radiation dose in achieving improved locoregional tumor control in limited stage small-cell lung carcinoma: An update. Int J Radiat Oncol Biol Phys 17:307-310, 1989
26. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336-344, 1993
27. Arriagada R, Le Chevalier T, Baldeyrou P, et al: Alternating radiotherapy and chemotherapy schedules in small-cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 11:1461-1467, 1985
28. Turrisi AT, Glover DJ, Mason BA: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 15:183-187, 1988
29. Mornex F, Trillett V, Chauvin F, et al: Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 19:23-30, 1990
30. Ihde DC, Grayson J, Woods E, et al: Limited stage small-cell lung cancer treated with concurrent etoposide/cisplatin and twice daily chest irradiation. Proceedings of 6th International Conference on the Adjuvant Therapy of Cancer. Tucson, AZ, 1990, p 37
31. Armstrong JG, Rosenstein MM, Kris MG, et al: Twice daily thoracic irradiation for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 21:1269-1274, 1991
32. Johnson DH, Kim K, Sause W, et al: Cisplatin + etoposide + thoracic radiotherapy administered once or twice daily in limited stage small cell lung cancer: Final report of intergroup trial 0096. Proc Am Soc Clin Oncol 15:374, 1996 (abstr)
33. Turrisi AT, Kim K, Sause W, et al: Observations after 5 year follow-up of Intergroup trial 0096: 4 cycles of cisplatin etoposide and concurrent 45 Gy thoracic radiotherapy given in daily or twice daily fractions followed by PCI. Survival differences and patterns of failure. Proc Am Soc Clin Oncol 17:457, 1998 (abstr)
34. Bonner JA, Shanahan TG, Brooks BJ, et al: Phase III comparison of once-daily thoracic radiation versus twice daily thoracic radiation in patients with limited stage small cell lung cancer. Proc Am Soc Clin Oncol 17:456, 1998 (abstr)